1. |
Amir A, Ghaferi KA, Chojnacki WD, et al. Pancreatic VIPomas:subject review and one institutional experience[J]. J Gastrointest Surg, 2008, 12(2):382-393.
|
2. |
Verner JV, Morrison AB. Islet cell tumor and a syndrome of refractory diarrhoea and hypokalemia[J]. Am J Med, 1958, 25(3):374-380.
|
3. |
陈家伟, 何戎华, 薛婉芬.胰性霍乱[J].中华内科杂志, 1977, 2(6):387-388.
|
4. |
王祖森, 吴力群, 赫建帅, 等.胰腺血管活性肠肽瘤1例报告暨国内文献复习[J].中国普通外科杂志, 2010, 19(3):330-332.
|
5. |
Kane MG, O'Dorisio TM, Krejs GJ. Production of secretory diarrhea by intravenous infusion of vasoactive intestinal polypeptide[J]. N Engl J Med, 1983, 309(24):1482-1485.
|
6. |
Cynthia Ro, Wanxing Chai, Victoria E. Yu, et al. Pancreatic neuroendocrine tumors:biology, diagnosis, and treatment[J]. Chin J Cancer, 2013, 32(6):312-324.
|
7. |
Adam N, Lim SS, Ananda V, et al. VIPoma syndrome:challen-ges in management[J]. Singapore Med J, 2010, 51(7):e129-e132.
|
8. |
Brunt LM, Mazoujian G, O'Dorisio TM, et al. Stimulation of vasoactive intestinal peptide and neurotensin secretion by pentagastrin in a patient with VIPoma syndrome[J]. Surgery, 1994, 115(3):362-369.
|
9. |
Legmann P, Vignaux O'Dousset B, et al. Pancreatic tumors:comparison of dual-phase helical CT and endoscopic sonography[J]. Am J Roentgenol, 1998, 170(5):1315-1322.
|
10. |
Sofka CM, Semelka RC, Marcos HB, et al. MR imaging of metastatic pancreatic VIPoma[J]. Magn Reson Imaging, 1997, 15(10):1205-1208.
|
11. |
Thomason JW, Martin RS, Fincher ME. Somatostatin receptor scintigraphy:the definitive technique for characterizing vasoactive intestinal peptide-secreting tumors[J]. Clin Nucl Med, 2000, 25(9):661-664.
|
12. |
Nikou GC, Toubanakis C, Nikolaou P, et al. VIPomas:an update in diagnosis and management in a series of 11 patients[J]. Hepatogastroenterology, 2005, 52(64):1259-1265.
|
13. |
Remme CA, de Groot GH, Schrijver G. Diagnosis and treatment of VIPoma in a female patient[J]. Eur J Gastroenterol Hepatol, 2006, 18(1):93-99.
|
14. |
Kulke MH, Anthony LB, Bushnell DL, et al. NANETS treatment guidelines:well-differentiated neuroendocrine tumors of the stomach and pancreas[J]. Pancreas, 2010, 39(6):735-752.
|
15. |
Shaib W, Mitchell K, Saif MW. Amelioration of symptoms and reduction of VIP levels after hepatic artery chemoembolization in a patient with sandostatin resistant VIPoma[J]. Yale J Biol Med, 2010, 83(1):27-33.
|
16. |
Johnston PC, Ardill JE, Johnston BT, et al. Vasoactive intestinal polypeptide secreting pancreatic tumour with hepatic metastases:long term survival after orthotopic liver transplantation[J]. Ir J Med Sci, 2010, 179(3):439-441.
|
17. |
Soga J, Yakuwa Y. VIPoma/diarrheogenic syndrome:a statistical evaluation of 241 reported cases[J]. J Exp Clin Cancer Res, 1998, 17(4):389-400.
|